118 related articles for article (PubMed ID: 6766286)
1. Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.
Moss RB; Lewiston NJ
Am Rev Respir Dis; 1980 Jan; 121(1):23-9. PubMed ID: 6766286
[TBL] [Abstract][Full Text] [Related]
2. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
3. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
[TBL] [Abstract][Full Text] [Related]
4. Immune complexes in cystic fibrosis.
Schiotz PO; Hoiby N; Juhl F; Permin H; Nielsen H; Svehag SE
Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):57-64. PubMed ID: 300210
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
6. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.
Hann S; Holsclaw DS
Infect Immun; 1976 Jul; 14(1):114-7. PubMed ID: 820637
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis.
Dasgupta MK; Lam J; Döring G; Harley FL; Zuberbuhler P; Lam K; Reichert A; Costerton JW; Dossetor JB
J Clin Lab Immunol; 1987 May; 23(1):25-30. PubMed ID: 3112403
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of circulating immune complexes in cystic fibrosis.
Moss RB; Hsu YP
Clin Exp Immunol; 1982 Feb; 47(2):301-8. PubMed ID: 6804143
[TBL] [Abstract][Full Text] [Related]
9. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa: immune status in patients with cystic fibrosis.
Doggett RG; Harrison GM
Infect Immun; 1972 Oct; 6(4):628-35. PubMed ID: 4628901
[TBL] [Abstract][Full Text] [Related]
11. Quantitative studies on immunologically specific and non-specific absorption of Pseudomonas aeruginosa antibodies in serum from cystic fibrosis patients.
Høiby N; Hertz JB
Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):185-92. PubMed ID: 6797245
[TBL] [Abstract][Full Text] [Related]
12. Activated complement in the sputum from patients with cystic fibrosis.
Schiøtz PO; Sørensen H; Høiby M
Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):1-5. PubMed ID: 433601
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Holby N; Olling S
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
[TBL] [Abstract][Full Text] [Related]
14. IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis.
Casaulta C; Schöni MH; Weichel M; Crameri R; Jutel M; Daigle I; Akdis M; Blaser K; Akdis CA
Pediatr Res; 2003 Feb; 53(2):313-9. PubMed ID: 12538792
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.
Høiby N; Wiik A
Scand J Respir Dis; 1975 May; 56(1):38-46. PubMed ID: 238280
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
17. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
[TBL] [Abstract][Full Text] [Related]
18. Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.
Dasgupta MK; Zuberbuhler P; Abbi A; Harley FL; Brown NE; Lam K; Dossetor JB; Costerton JW
J Clin Immunol; 1987 Jan; 7(1):51-8. PubMed ID: 3104391
[TBL] [Abstract][Full Text] [Related]
19. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
20. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
